Search results for

Cheap manufacturing costs and a growing domestic demand for branded goods have made India a new centre of counterfeiting. Taj Kunwar Paul and Ranjan Narula explain what companies can do to protect their products

Stephen Gare of Mayer, Brown, Rowe & Maw in London examines how best to enforce IP rights in the UK, in the light of reforms to the court system

Latest developments in trade mark law Recent years have seen fundamental changes to trade mark protection in China. Yi Wang of Wang & Associates reviews the development of the law, and looks at some issues that have caused controversy

A new law introduced major changes affecting all IP rights last year. Andrzej Pyrza of Patpol Ltd in Warsaw explains that the changes bring Poland closer to EU harmonization

Following James Rogan's exit earlier this year, a new director will soon be appointed to run the world's biggest patent office - the USPTO. With rising costs, debates over patent policy and complaints about patent quality and pendency, there are many issues that urgently need tackling. MIP invited six professionals with experience of working with - and inside - the USPTO to discuss the direction of the Office. In a debate moderated by Sam Mamudi, they considered whether Rogan's far-reaching reform proposals address the needs of users

Two recent studies of the US patent system have sparked debate about correcting the balance between the rights of patent owners and the interests of society. Sam Mamudi examines the issues under scrutiny

An overlooked fact of the new Sarbanes-Oxley Act in the US is the impact it will have on IP reporting procedures. Stacey Rabbino and Ken Godlewski explain how in-house counsel can ensure compliance with the new standards

Pre-trial injunctions offer an alternative to administrative actions and the Civil Procedure Law in IP litigation in China. To benefit properly from them, however, you should follow procedures carefully, warns Matthew Murphy

Emma Barraclough, Hong Kong and Stéphanie Bodoni, London

The last few years have seen an earnest push by the Singapore government to develop the biotechnology sector in this island city-state. Indeed, biotechnology was to be the fourth pillar of the country's economy. The Straits Times recently reported that the government is spending US$1.7 billion over a period of five years to attract foreign biotech and pharmaceutical companies to Singapore.